Tatsis Ourania sold VRTX
July 2, 2026 · Form 4 insider transaction
Tatsis Ourania sold 1,500 shares of Vertex Pharmaceuticals Incorporated at $524.99 per share, a transaction worth $787.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,500
Price
$524.99
Total value
$787.5K
InsiderTatsis Ourania
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 2, 2026
Filing dateJuly 7, 2026
Shares owned after45,321
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.